FdaApplication
NDA 020251
Identifiers
- fda_app_no: NDA020251
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1994-03-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZANTAC 150 | RANITIDINE HYDROCHLORIDE | EQ 150MG BASE | TABLET, EFFERVESCENT;ORAL |
| ZANTAC 150 | RANITIDINE HYDROCHLORIDE | EQ 150MG BASE/PACKET | GRANULE, EFFERVESCENT;ORAL |
| ZANTAC 25 | RANITIDINE HYDROCHLORIDE | EQ 25MG BASE | TABLET, EFFERVESCENT;ORAL |
3 products